State Of New Jersey Common Pension Fund D Travere Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$7.64 - $17.25 $1.45 Million - $3.27 Million	189,415 New	189,415 $1.69 Million
Q3 2022 Oct 28, 2022	BUY	$22.91 - $28.63 $1.97 Million - $2.46 Million	86,045 New	86,045 $2.12 Million
Q2 2021 Jul 23, 2021	SELL	$14.11 - $26.4 $1.17 Million - $2.19 Million	-82,981 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$23.37 - $31.77 $1.94 Million - $2.64 Million	82,981 New	82,981 $2.07 Million

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.